This new 247-page report from VPGMarketResearch provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2015-2019 Future Horizons and Growth Strategies in the UK Therapeutic Drug Monitoring (TDM) Market is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 247 pages and 17 tables
SIMILAR MARKET STUDIES
About This ReportThis new 282-page report from VPGMarketResearch.com presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share ...
August 2015 | $1250 | View Details >>
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch.com's new report is a five-country strategic analysis of major business opportunities emerging in the European clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in major European countries (France, Germany, Italy, Spain, UK); provides ...
March 2017 | $0 | View Details >>
This new report from Venture Planning Group provides analysis of LDH testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
June 2014 | $0 | View Details >>
2017 Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape-US, Europe (France, Germany, Italy, Spain, UK), Japan
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to ...
March 2017 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research